Allergic Reaction
Top in allergy/asthma: FDA OKs Xolair; commercial sparks conversation about food allergies
The FDA has approved Xolair for the reduction of allergic reactions in children and adults with immunoglobulin E-mediated food allergy, according to a press release from Roche.
FDA grants priority review to omalizumab in treatment of food allergy
The FDA has accepted a supplemental biologics application for the use of omalizumab to reduce allergic reactions due to accidental exposure in patients aged 1 year and older with at least one food allergy, according to a press release.
COVID-19 revaccination shows low risk for repeated immediate, severe allergic reactions
Individuals who had an immediate allergic reaction to a first SARS-CoV-2 mRNA vaccine showed a low risk for an immediate or severe allergic reaction following the second dose, according to results of a systemic review and meta-analysis.
COVID-19 revaccination following allergic reaction safe with diagnostic workup
Revaccination among patients with suspected allergic reactions to the COVID-19 vaccine appeared safe after diagnostic workup to assess for drug excipient allergy, according to data published in Clinical and Translational Allergy.
Data support second COVID-19 vaccine dose, even when allergic reaction occurs with first
Most patients with “immediate and potentially allergic reactions” to the Pfizer/BioNTech and Moderna COVID-19 vaccines tolerated a second dose, researchers reported in JAMA Internal Medicine.
Reactions during breastfeeding may signal allergies later in life
Symptoms of allergic reaction to certain foods during breastfeeding may signal a child’s food allergies later in life, data presented at the annual meeting of the American Academy of Allergy, Asthma & Immunology showed.
Q&A: ACAAI releases guidance about Pfizer's COVID-19 vaccine in patients with allergies
The American College of Allergy, Asthma and Immunology’s COVID-19 Task Force released guidance on allergic reaction risk from the Pfizer-BioNTech COVID-19 vaccine.
Viaskin Peanut patch increases protection from allergy over time
In the largest long-term peanut immunotherapy trial to date, the epicutaneous immunotherapy patch known as Viaskin Peanut increased patients’ protection over time from allergic reactions, according to researchers.
Young children visiting ED more, hospitalized less for anaphylaxis
HOUSTON — Between 2006 to 2015, the number of children aged younger than 3 years who visited the ED for anaphylaxis increased, but the number of subsequent hospitalizations decreased, according to findings presented at the American College of Asthma, Allergy & Immunology Scientific Meeting.